← Back to Patent Explorer
US5296500A Expired / Lapsed US ⏱️ 0.0 years remaining

Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy

Assignee: TEXTILE RESEARCH INSTITUTE Inc
•
Filing: 1993-07-30
•
Granted: 1994-03-22
•
Expires: 2013-07-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of N-acetyl-L-cysteine and/or a derivative thereof.

Inventors

  • 👤 Greg G. Hillebrand

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 12:45
CPC Classifications
A; A61; A61Q; A61Q19/00; A61K; A61K8/00; A61K8/18; A61K8/30; A61K8/40; A61K8/44; A61K8/447; A61Q19/08; A61Q17/00; A61Q17/04

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 46 words
A method for regulating wrinkles or atrophy in mammalian skin comprising treating skin in need of such regulation with a safe and effective amount of a composition comprising: a) a safe and effective amount of N-acetyl-L-cysteine or a pharmaceutically-acceptable salt thereof, and b) a pharmaceutically-acceptable carrier.
Claim 2
Independent Claim 46 words
A method for regulating wrinkles or atrophy in mammalian skin comprising treating skin in need of such regulation with a safe and effective amount of a composition comprising: a) a safe and effective amount of N-acetyl-L-cysteine or a pharmaceutically-acceptable salt thereof, and b) a pharmaceutically-acceptable carrier.
Claim 3
Dependent Claim 18 words
The method of claim 1 wherein the composition comprises from about 0.01% to about 50% of the compound.
Claim 4
Dependent Claim 18 words
The method of claim 1 wherein the composition comprises from about 0.1% to about 20% of the compound.
Claim 5
Dependent Claim 13 words
The method of claim 2 wherein the pharmaceutically-acceptable carrier is a topical carrier.
Claim 6
Dependent Claim 16 words
The method of claim 4 wherein the treatment of the skin with the composition is chronic.
Claim 7
Dependent Claim 39 words
The method of claim 5 wherein the treatment of the skin with the composition is for a period of at least about six months comprising application of the composition from about once per week to about two times daily.
Claim 8
Independent Claim 23 words
The method of any of claims 4 and 5 wherein the composition additionally comprises a safe and effective amount of a zinc salt.
Claim 9
Independent Claim 34 words
The method of any of claims 4 and 5 wherein the composition additionally comprises a zinc salt selected from the group consisting of zinc oxide, zinc stearate, zinc sulfate, zinc chloride and zinc acetate.
Claim 10
Independent Claim 23 words
The method of any of claims 4 and 5 wherein the composition additionally comprises a safe and effective amount of a sunscreening agent.
Claim 11
Independent Claim 43 words
The method of any one of claims 4 and 5 wherein the composition additionally comprises another active agent selected from the group consisting of a safe and effective amount of an anti-inflammatory agent, an anti-oxidant, a chelator, a retinoid, and a benzofuran derivative.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-03-21 1997-09-20 1998-03-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-03-21 2001-09-20 2002-03-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-03-21 2005-09-20 2006-03-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag